MDS Nordion has completed its new $20-million cyclotron in Vancouver where it is co-located with TRIUMF. The cyclotron will begin producing radioisotopes in April, starting with thallium-201, which is used as a heart imaging agent. The cyclotron will double MDS Nordion’s production capacity and result in 20 new jobs....